Requires public hospitals to establish auto-immune disease treatment centers; authorizes the commissioner of health, with the assistance of the office of health equity, to make funds available to public hospitals for such purpose.
Summary
Bill A05118 mandates that all public hospitals in New York establish auto-immune disease treatment centers. The bill defines these centers as facilities dedicated to the construction, renovation, and equipping of spaces specifically for the treatment of auto-immune diseases. The New York State Commissioner of Health is tasked with overseeing the implementation of this requirement and is authorized to allocate state funds to support the establishment and operation of these centers. Additionally, the Office of Health Equity will assist in the distribution of funds and the development of methodologies for their allocation.
Impact
The passage of this bill will significantly impact public health law in New York by creating a new requirement for public hospitals, which are defined as those operated by counties or municipalities and receiving state funding. It will lead to the establishment of specialized treatment centers for auto-immune diseases, potentially improving patient care and outcomes for individuals suffering from these conditions. The bill also sets a framework for state funding and oversight, which may affect budget allocations within the health department.
Sentiment
The sentiment surrounding Bill A05118 appears to be generally supportive, as it addresses a critical area of healthcare that affects many individuals. However, there may be concerns regarding the funding and resources required for hospitals to comply with this mandate, as well as the potential impact on existing healthcare services. No formal votes or committee discussions have been recorded yet, indicating that the bill is still in the early stages of consideration.
Contention
Points of contention may arise regarding the financial implications for public hospitals, particularly in terms of funding and resource allocation. Some stakeholders may argue that the requirement to establish these centers could strain hospital budgets, especially in areas with limited resources. Additionally, there may be differing opinions on the prioritization of auto-immune disease treatment centers compared to other pressing healthcare needs.
Same As
Requires public hospitals to establish auto-immune disease treatment centers; authorizes the commissioner of health, with the assistance of the office of health equity, to make funds available to public hospitals for such purpose.
Requires public hospitals to establish auto-immune disease treatment centers; authorizes the commissioner of health, with the assistance of the office of health equity, to make funds available to public hospitals for such purpose.
An Act Establishing Licensure For Long-term Acute Care Hospitals And Requiring The Department Of Public Health To Study The Designation Of Long-term Care Facilities And Chronic Disease Hospitals.
Relates to the publication of immunization information; requires schools to provide immunization information to the commissioner of health; requires the department of health to make immunization information, including rates of immunization, available on its website.
Authorizes the commissioner of health to make grants for purposes of preventing transmission of tick-borne diseases on public lands frequented by humans; requires the commissioner to submit an annual report on the performance of programs funded by such grants.
Authorizes the commissioner of health to make grants for purposes of preventing transmission of tick-borne diseases on public lands frequented by humans; requires the commissioner to submit an annual report on the performance of programs funded by such grants.
Commissioner of health required to establish a provider orders for life-sustaining treatment program, rulemaking authorized, data classified, immunity established for certain acts, and money appropriated.
Authorizes a licensed pharmacist to administer any recommendations made by the commissioner of health pertaining to a vaccine that has been authorized by the federal Food and Drug Administration; relates to insurance coverage for immunizations; removes the requirement to follow the advisory committee on immunization practices of the centers for disease control and prevention recommendation for immunization against meningococcal disease.
Requires the health equity council to issue mandates related to the treatment of sickle cell disease; requires the commissioner of health to adhere to and act upon the recommendations and mandates of the health equity council.
Authorizes a licensed pharmacist to administer any recommendations made by the commissioner of health pertaining to a vaccine that has been authorized by the federal Food and Drug Administration; relates to insurance coverage for immunizations; removes the requirement to follow the advisory committee on immunization practices of the centers for disease control and prevention recommendation for immunization against meningococcal disease.